コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 Texas, and the Philippines in 1996 (subtype Reston).
2 ines and Reston, Virginia, isolates [subtype Reston]).
3 es, Sudan and Cote d'Ivoire, as well as from Reston, a strain thought to be nonpathogenic in humans,
9 rus activity against Bundibugyo, Tai Forest, Reston, and Mengla viruses and is the first submicromola
10 IgM capture assay detected anti-EBO (subtype Reston) antibodies in the sera of 5 of 5 experimentally
11 f a human who was infected with EBO (subtype Reston) during a postmortem examination of an infected m
12 mong the filoviruses characterized thus far, Reston Ebola virus (REBOV) is the only Ebola virus that
13 interaction, Zaire, mouse-adapted Zaire, and Reston Ebola virus VP24s displayed similar capacities to
15 roteins from Zaire, mouse-adapted Zaire, and Reston Ebola viruses for interaction with all six member
18 ells infected with Zaire Ebolavirus (ZEBOV), Reston Ebolavirus (REBOV), and Marburgvirus (MARV), usin
20 us (EBOV), Bundibugyo ebolavirus (BDBV), and Reston ebolavirus (RESTV) belong to the same genus but e
21 raced back only within the last 50 years for Reston ebolavirus and Zaire ebolavirus species and sugge
22 re, but more slowly progressive illness; and Reston Ebolavirus caused mild disease that was late in o
23 divided into five distinct species, of which Reston ebolavirus is uniquely nonpathogenic to humans.
26 Marburg marburgvirus, Tai Forest ebolavirus, Reston ebolavirus, Sudan ebolavirus, Zaire ebolavirus, a
29 la virus (subsequently identified as subtype Reston) infection among cynomolgus monkeys imported from
31 equirements, put in place after the original Reston outbreak in 1989-1990, were effective for detecti
36 et of recombinant surface glycoproteins from Reston, Tai Forest, Bundibugyo, Zaire, Sudan, and Marbur
42 ns, ranging from asymptomatic infections for Reston virus (RESTV) to severe disease with fatal outcom
48 rus, respectively and (iv) antibodies to the Reston virus GP for which no antibodies have been report
49 been proposed to be critical for the lack of Reston virus human pathogenicity because they alter the
50 novel hosts, and only a few SDPs distinguish Reston virus VP24 from VP24 of other Ebolaviruses, human
51 c of an ebolavirus nonpathogenic for humans (Reston virus) and that of an ebolavirus with lower letha
52 n virus, Tai Forest virus, Bundibugyo virus, Reston virus, and Marburg virus and differentiated betwe
57 a fascicularis) infected with Ebola (subtype Reston) virus in a US-registered quarantine facility.
60 ll nine Ebolavirus proteins that distinguish Reston viruses from the four human pathogenic Ebolavirus